West Lafayette, Indiana - Purdue University researchers think the gap between a psychologists’ diagnosis and a patient’s self-evaluation might not be as extreme as previously perceived when both are using the same evaluation tools.

Washington, DC - Tyson Foods Inc., a North Little Rock, Ark. establishment, is recalling approximately 3,120 pounds of frozen breaded chicken products that may be contaminated with extraneous materials, specifically blue and clear soft plastic, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced Friday.

Washington, DC - American Heart Association CEO Nancy Brown issued the following comments on the 2017 National Youth Tobacco Survey (NYTS),  released today by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration’s (FDA) Center for Tobacco Products. The new 2017 survey data indicates that 3.6 million middle and high school students used tobacco in the last 30 days. Of the 3.6 million, 2.1 million used e-cigarettes. The number of young people surveyed who smoked e-cigarettes in 2017 is very close to the 2016 total when e-cigarette use came in just under 2.2 million:

Washington, DC - Scientists have discovered that the absence of a specific protein in cells lining the esophagus may cause inflammation and tissue damage in people with eosinophilic esophagitis (EoE).  EoE affects as many as 150,000 people in the United States, many of whom are children. People with EoE experience difficult or painful swallowing, vomiting and nutritional problems because an accumulation of immune cells called eosinophils scars the esophagus.

Dallas, Texas - Limited healthy literacy is a major barrier blocking many people from achieving good cardiovascular health or benefiting from effective treatment for heart attacks, heart failure, strokes and other cardiovascular diseases, according to a scientific statement published in the American Heart Association’s journal Circulation.

Washington, DC - A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., chief of the Surgery Branch at NCI’s Center for Cancer Research (CCR), and the findings were published June 4, 2018 in Nature Medicine. NCI is part of the National Institutes of Health.